Stockreport

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA deliv [Read more]